NASDAQ:MTBC - Medical Transcription Billing Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Medical Transcription Billing Corp Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $4.23 -0.02 (-0.47 %) (As of 12/6/2019 01:02 AM ET) Add Compare Today's Range$4.20Now: $4.23▼$4.3050-Day Range$3.57MA: $3.89▼$4.2752-Week Range$3.25Now: $4.23▼$5.50Volume45,320 shsAverage Volume48,797 shsMarket Capitalization$51.69 millionP/E RatioN/ADividend YieldN/ABeta1.77 ProfileAnalyst RatingsAdvanced ChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Medical Transcription Billing, Corp. is a healthcare information technology company that provides an integrated suite of Web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. The Company's offering, PracticePro, allows healthcare practices with the core software and business services on Software-as-a-Service (SaaS) platform. Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry Prepackaged software Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:MTBC Previous Symbol CUSIPN/A CIK1582982 Webhttp://www.mtbc.com/ Phone732-873-5133Debt Debt-to-Equity Ratio0.07 Current Ratio2.31 Quick Ratio2.27Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$50.55 million Price / Sales1.02 Cash Flow$0.07 per share Price / Cash Flow62.12 Book Value$3.29 per share Price / Book1.29Profitability EPS (Most Recent Fiscal Year)($0.59) Net Income$-2,140,000.00 Net Margins-5.01% Return on Equity-8.85% Return on Assets-6.64%Miscellaneous Employees2,400 Outstanding Shares12,219,000Market Cap$51.69 million Next Earnings Date3/18/2020 (Estimated) OptionableNot Optionable Receive MTBC News and Ratings via Email Sign-up to receive the latest news and ratings for MTBC and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:MTBC Rates by TradingView Medical Transcription Billing (NASDAQ:MTBC) Frequently Asked Questions What is Medical Transcription Billing's stock symbol? Medical Transcription Billing trades on the NASDAQ under the ticker symbol "MTBC." How were Medical Transcription Billing's earnings last quarter? Medical Transcription Billing Corp (NASDAQ:MTBC) posted its earnings results on Wednesday, November, 6th. The technology company reported ($0.14) earnings per share for the quarter, meeting the Zacks' consensus estimate of ($0.14). The technology company had revenue of $16.85 million for the quarter, compared to analyst estimates of $16.06 million. Medical Transcription Billing had a negative return on equity of 8.85% and a negative net margin of 5.01%. View Medical Transcription Billing's Earnings History. When is Medical Transcription Billing's next earnings date? Medical Transcription Billing is scheduled to release their next quarterly earnings announcement on Wednesday, March 18th 2020. View Earnings Estimates for Medical Transcription Billing. What guidance has Medical Transcription Billing issued on next quarter's earnings? Medical Transcription Billing issued an update on its FY 2019 earnings guidance on Tuesday, October, 15th. The company provided EPS guidance of for the period. The company issued revenue guidance of $62.677 million, compared to the consensus revenue estimate of $64.4 million. What price target have analysts set for MTBC? 4 brokers have issued 12 month price objectives for Medical Transcription Billing's shares. Their forecasts range from $6.00 to $6.25. On average, they anticipate Medical Transcription Billing's share price to reach $6.08 in the next year. This suggests a possible upside of 43.8% from the stock's current price. View Analyst Price Targets for Medical Transcription Billing. What is the consensus analysts' recommendation for Medical Transcription Billing? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medical Transcription Billing in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Medical Transcription Billing. Has Medical Transcription Billing been receiving favorable news coverage? News stories about MTBC stock have been trending somewhat positive on Thursday, InfoTrie reports. The research firm rates the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Medical Transcription Billing earned a media sentiment score of 1.3 on InfoTrie's scale. They also assigned press coverage about the technology company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for Medical Transcription Billing. Are investors shorting Medical Transcription Billing? Medical Transcription Billing saw a decrease in short interest in November. As of November 15th, there was short interest totalling 42,000 shares, a decrease of 64.7% from the October 31st total of 119,000 shares. Based on an average daily volume of 29,800 shares, the short-interest ratio is presently 1.4 days. Approximately 0.7% of the company's stock are sold short. View Medical Transcription Billing's Current Options Chain. Who are some of Medical Transcription Billing's key competitors? Some companies that are related to Medical Transcription Billing include Red Violet (RDVT), Iclick Interactive Asia Group (ICLK), Smith Micro Software (SMSI), Inspired Entertainment (INSE), MAM Software Group (MAMS), SharpSpring (SHSP), Great Elm Capital Group (GEC), Cyren (CYRN), Gridsum (GSUM), Aware (AWRE), Mobivity (MFON), Astea International (ATEA), NetSol Technologies (NTWK), Audioeye (AEYE) and Where Food Comes From (WFCF). What other stocks do shareholders of Medical Transcription Billing own? Based on aggregate information from My MarketBeat watchlists, some companies that other Medical Transcription Billing investors own include BlackBerry (BB), NVIDIA (NVDA), Sophiris Bio (SPHS), Verastem (VSTM), Advanced Micro Devices (AMD), Microbot Medical (MBOT), Micron Technology (MU), Alibaba Group (BABA), Etsy (ETSY) and Interpace Diagnostics Group (IDXG). How do I buy shares of Medical Transcription Billing? Shares of MTBC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is Medical Transcription Billing's stock price today? One share of MTBC stock can currently be purchased for approximately $4.23. How big of a company is Medical Transcription Billing? Medical Transcription Billing has a market capitalization of $51.69 million and generates $50.55 million in revenue each year. The technology company earns $-2,140,000.00 in net income (profit) each year or ($0.59) on an earnings per share basis. Medical Transcription Billing employs 2,400 workers across the globe.View Additional Information About Medical Transcription Billing. What is Medical Transcription Billing's official website? The official website for Medical Transcription Billing is http://www.mtbc.com/. How can I contact Medical Transcription Billing? Medical Transcription Billing's mailing address is 7 CLYDE ROAD, SOMERSET NJ, 08873. The technology company can be reached via phone at 732-873-5133. MarketBeat Community Rating for Medical Transcription Billing (NASDAQ MTBC)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 211 (Vote Outperform)Underperform Votes: 211 (Vote Underperform)Total Votes: 422MarketBeat's community ratings are surveys of what our community members think about Medical Transcription Billing and other stocks. Vote "Outperform" if you believe MTBC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MTBC will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/6/2019 by MarketBeat.com StaffFeatured Article: Why are percentage decliners important?